CSF levels of FABP3, MDH1, and GDI1 were significantly different within the MCI group, with a highly significant elevation in MCI cases with amyloid abnormalities compared to amyloid-negative MCI cases (Fig. 6 C-D).
← all excerpts
A microglial activity state biomarker panel differentiates FTD-granulin and Alzheimer's disease patients from controls.
1
—
—